ProPhase Labs, Inc.

Form D Filings

Location
Uniondale, NY
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0000868278
Previous Names
ProPhase Labs, Inc., QUIGLEY CORP
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
8/5/2025 Debt, Option to Acquire $3,000,000 $6,000,000 $3,000,000 7/22/2025 8/5/2025 D 000164117225022239
7/7/2025 Debt, Option to Acquire $1,000,000 $1,000,000 $0 6/22/2025 7/7/2025 D 000164117225017941
12/28/2015 Debt, Option to Acquire, Security to be Acquired $1,500,000 $3,000,000 $1,500,000 12/11/2015 12/24/2015 D 000138296315000141
3/26/2010 Equity $2,923,200 $2,923,200 $0 3/22/2010 3/26/2010 D 000114420410015737